Document:

Translated by WordPort from WordPerfect 6.x (Dos/Windows) document 1197926.1

THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SUCH ACT AND/OR APPLICABLE STATE SECURITIES LAWS, OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

Issue Date:  ____________, 2017

WARRANT TO PURCHASE SHARES

of

ZEC, INC.

THIS CERTIFIES THAT, for value received, ___________________, or its registered assigns (the “Holder”), is entitled, subject to the terms and conditions set forth herein, to purchase from ZEC, INC., a Delaware corporation (the “Company”), Shares (as defined below), in the amounts, at such times and at the price per share set forth herein.  The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein.

1.

Purchase of Shares.  Subject to the terms and conditions herein, including the exercise period set forth in Section 2, the Holder is entitled, upon surrender of this Warrant to the Company, to purchase from the Company ________________ Thousand (_____,000) shares (the “Shares”) of common stock of the Company (the “Common Stock”)..

2.

Exercise Period and Price.

(a)

Exercise Period.  The Warrant shall be exercisable as to one-half (1/2) of the Shares during the term commencing on the Issue Date and ending on the expiration of this Warrant pursuant to Section 14 hereof.  The Warrant shall be exercisable as to the remaining one-half (1/2) of the Shares during the term commencing on ________________, and ending on the expiration of this Warrant pursuant to Section 14 hereof. 

(b)

Exercise Price.  The exercise price for the Shares (the “Exercise Price”) shall be $0.50 per Share.

1.

Method of Exercise.  While this Warrant remains outstanding and exercisable, the Holder may exercise, in whole or in part, the purchase rights evidenced hereby.  Such exercise shall be effected by (i) the surrender of this Warrant, together with a notice of exercise, in substantially the form attached as Exhibit A, to the Secretary of the Company at its principal offices and (ii) the payment to the Company of the aggregate Exercise Price for the number of Shares being purchased.

2.

Net Exercise.  In lieu of cash exercising this Warrant, the Holder may elect to receive shares equal to the value of this Warrant (or the portion thereof being canceled) by surrender of this Warrant to the Company together with notice of such election, in which event the Company shall issue to the Holder hereof a number of Shares computed using the following formula:

Y (A - B)

X = 

       A

Where

X --

The number of Shares to be issued to the Holder.

Y --

The number of Shares purchasable under this Warrant.

A --

The fair market value of one Share.

B --

The Exercise Price (as adjusted to the date of such calculations).

For purposes of this Section 4, the fair market value of a Share shall mean the average of the closing bid and asked prices of Shares (or the Common Stock underlying the Shares, if applicable) quoted in the over-the-counter market in which the Shares (or the Common Stock underlying the Shares, if applicable) are traded or the closing price quoted on any exchange on which the Shares (or the Common Stock underlying the Shares, if applicable) are listed, whichever is applicable, as published in the Western Edition of The Wall Street Journal for the twenty (20) trading days prior to the date of determination of fair market value (or such shorter period of time during which such stock was traded over-the-counter or on such exchange).  In the event that this Warrant is exercised pursuant to this Section 4 in connection with the Company’s initial public offering, the fair market value per Share shall be the product of (i) the per share offering price to the public of the Company’s initial public offering, and (ii) the number of shares of Common Stock into which each Share is convertible at the time of such exercise or, if the Shares are shares of Common Stock, one.  If the Shares are not traded on the over-the-counter market or on an exchange, the fair market value shall be determined in good faith by the Company’s Board of Directors.

3.

Certificates for Shares.  As soon as practicable upon the exercise of this Warrant, the Company shall issue the Holder a certificate for the number of Shares so purchased and, if such exercise is in part, a new warrant (dated the date hereof) of like tenor representing the remaining number of Shares purchasable under this Warrant.

4.

Issuance of Shares.  The Company covenants that the Shares, when issued pursuant to the exercise of this Warrant, will be duly and validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issuance thereof.

5.

Adjustment of Exercise Price and Number of Shares.  The number of and kind of securities purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows:

(a)

Subdivisions, Combinations and Other Issuances.  If the Company shall at any time prior to the expiration of this Warrant subdivide the Shares (or the Common Stock underlying the Shares, if applicable), by splitup or otherwise, or combine its Shares (or the Common Stock underlying the Shares, if applicable), or issue additional shares of its Shares (or the Common Stock underlying the Shares, if applicable) as a dividend, the number of Shares issuable on the exercise of this Warrant shall be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination.  Appropriate adjustments shall also be made to the purchase price payable per share, but the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same.  Any adjustment under this Section 7(a) shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or if no record date is fixed, upon the making of such dividend.

(b)

Reclassification, Reorganization and Consolidation.  In case of any reclassification, capital reorganization, or change in the capital stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 7(a) above), then the Company shall make appropriate provision so that the Holder shall have the right at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities and property receivable in connection with such reclassification, reorganization, or change by a holder of the same number of Shares as were purchasable by the Holder immediately prior to such reclassification, reorganization, or change.  In any such case appropriate provisions shall be made with respect to the rights and interest of the Holder so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise hereof, and appropriate adjustments shall be made to the purchase price per share payable hereunder, provided the aggregate purchase price shall remain the same.

Notice of Adjustment.  When any adjustment is required to be made pursuant to this Section 7, the Company shall promptly notify the Holder of such event and of the number of Shares or other securities or property thereafter purchasable upon exercise of this Warrant.

1.

Reservation of Stock.  The Company agrees during the term the rights under this Warrant are exercisable to reserve and keep available from its authorized and unissued Shares for the purpose of effecting the exercise of this Warrant such number of Shares (and shares of Common Stock for issuance upon conversion of such Shares, if applicable) as shall from time to time be sufficient to effect the exercise of the rights under this Warrant.

2.

No Fractional Shares or Scrip.  No fractional shares or scrip representing fractional Shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional Shares the Company shall make a cash payment therefor on the basis of the exercise price then in effect.

3.

Representations of the Company.  The Company represents that all corporate actions on the part of the Company, its officers, directors and stockholders necessary for the sale and issuance of this Warrant have been taken.

4.

Representations and Warranties by the Holder.  The Holder represents and warrants to the Company as follows:

(a)

This Warrant and the Shares issuable upon exercise hereof are being acquired for its own account, for investment and not with a view to, or for resale in connection with, any distribution or public offering within the meaning of the Securities Act of 1933, as amended (the “Act”).

(b)

The Holder understands that this Warrant and the Shares have not been registered under the Act by reason of their issuance in a transaction exempt from the registration and prospectus delivery requirements of the Act pursuant to Section 4(2) thereof, and that they must be held by the Holder indefinitely, and that the Holder must therefore bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof is registered under the Act or is exempted from such registration.

(c)

The Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the acquisition of this Warrant and the Shares purchasable pursuant to the terms of this Warrant.

(d)

The Holder is able to bear the economic risk of the purchase of the Shares.

1.

Restrictive Legend.

The Shares (unless registered under the Act) shall be stamped or imprinted with a legend in substantially the following form:

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.  COPIES OF THE AGREEMENT COVERING THE PURCHASE OF THESE SHARES AND RESTRICTING THEIR TRANSFER MAY BE OBTAINED AT THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY.

2.

Warrants Transferable.  Subject to compliance with the terms and conditions of this Section 13, this Warrant and all rights hereunder are transferable, in whole or in part, without charge to the Holder (except for transfer taxes), upon surrender of this Warrant properly endorsed or accompanied by written instructions of transfer.  With respect to any offer, sale or other disposition of this Warrant prior to registration of such Warrant, the Holder agrees to give written notice to the Company prior thereto, describing briefly the manner thereof, together with a written opinion of such Holder’s counsel, if reasonably requested by the Company, to the effect that such offer, sale or other disposition may be effected without registration or qualification (under the Act or any federal or state securities law then in effect); provided, however, that no such opinion of counsel shall be required for (a) transfers made pursuant to Rule 144 under the Act or (b) transfers by a Holder (i) that is a partnership transferring to its partners or former partners in accordance with partnership interests, (ii) that is a corporation transferring to a wholly-owned subsidiary or parent corporation that owns all of the capital stock of the Holder, (iii) that is a limited liability company transferring to its members or former members in accordance with their interests in the limited liability company, (iv) that is an individual transferring to a family member or trust for the benefit of the Holder, or (v) to an Affiliate (as defined below).  Upon receiving such written notice and reasonably satisfactory opinion, if such opinion is required and requested by the Company, the Company, as promptly as practicable, shall notify such Holder that such Holder may sell or otherwise dispose of this Warrant in accordance with the terms of the notice delivered to the Company.  If a determination has been made that the opinion of counsel for the Holder is not reasonably satisfactory to the Company, the Company shall so notify the Holder promptly with details thereof after such determination has been made.  For the purposes hereof, an “Affiliate” shall mean a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the person specified.

3.

Expiration of Warrant.  This Warrant shall expire and no longer be exercisable upon the earlier of (a) the consummation of any Change of Control or (b) 5:00 p.m. Central time on the seven (7) year anniversary of the Issue Date of this Warrant.  The term “Change of Control” shall mean (i) any stock acquisition (but excluding any sale of stock for capital raising purposes), reorganization, merger or consolidation, other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity or (ii) a sale, lease or other disposition of all or substantially all of the assets of the Company.

4.

Notices.  All notices hereunder shall be effective when given, and shall be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid or (d) one business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy by first class mail, postage prepaid, and shall be addressed (i) if to the Holder, at ______________________________________ and (ii) if to the Company, at 1002 North Central Expressway, Suite 495, Richardson, TX 75080, or at such other address as the Company shall have furnished in writing.

5.

“Market Stand-Off” Agreement.  The Holder shall not sell or otherwise transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, of any Common Stock (or other securities) of the Company held by the Holder (other than those included in the registration) during the one hundred eighty (180) day period following the effective date of the registration statement for the Company’s initial public offering filed under the Act (or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (a) the publication or other distribution of research reports and (b) analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto), provided that all officers and directors of the Company and all holders of at least one percent (1%) of the Company’s voting securities are bound by and have entered into similar agreements.  The Company may impose stop-transfer with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of such one hundred eighty (180) day (or other) period.  The Holder agrees to execute a market standoff agreement with said underwriters in customary form consistent with the provisions of this Section.

6.

Governing Law.  This Warrant shall be governed by the laws of the State of Delaware, without regard to the conflicts of law provisions of any jurisdiction.

7.

Binding Arbitration.  Any dispute arising out of or in connection with this Warrant shall be resolved solely and exclusively by confidential binding arbitration with the San Jose, California branch of JAMS (“JAMS”) to be governed by JAMS’ Commercial Rules of Arbitration applicable at the time of the commencement of the arbitration (the “JAMS Rules”) and heard before one arbitrator.  The Holder and the Company shall attempt to mutually select the arbitrator.  In the event the Holder and the Company are unable to mutually agree, the arbitrator shall be selected by the procedures prescribed by the JAMS Rules.  The prevailing party will be entitled to reasonable attorneys’ fees, in addition to any other relief to which that party may be entitled.

8.

Rights and Obligations Survive Exercise of Warrant.  Unless otherwise provided herein, the rights and obligations of the Company, of the Holder and of the holder of the Shares issued upon exercise of this Warrant, shall survive the exercise of this Warrant.

9.

Amendments and Waivers.  No modification of or amendment to this Warrant, nor any waiver of any rights under this Warrant, will be effective unless in a writing signed by the Company and the Holder. Waiver by the Holder of a breach of any provision of this Warrant will not operate as a waiver of any other or subsequent breach.

[Signature page follows]

GRELLAS-#83334-v1-Warrant_-_Bedminster_Financial_Group

The Company has caused this Warrant to be issued as of the date first written above.

ZEC, INC.,

a Delaware corporation

By:  

Name:  

Title:  

GRELLAS-#83334-v1-Warrant_-_Bedminster_Financial_Group

EXHIBIT A

NOTICE OF EXERCISE

TO:

ZEC, INC.

1.

The undersigned hereby elects to purchase 

 shares of common stock of ZEC, Inc. pursuant to the terms of the attached Warrant.

2.

Method of Exercise (Please initial the applicable blank):

  The undersigned elects to exercise the attached Warrant by means of a cash payment, and tenders herewith payment in full for the purchase price of the shares being purchased, together with all applicable transfer taxes, if any.

  The undersigned elects to exercise the attached Warrant by means of the net exercise provisions of Section 4 of the Warrant.

3.

Please issue a certificate or certificates representing said Shares in the name of the undersigned or in such other name as is specified below:

(Name)

(Address)

4.

The undersigned hereby represents and warrants that the aforesaid Shares are being acquired for the account of the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares and all representations and warranties of the undersigned set forth in Section 11 of the attached Warrant are true and correct as of the date hereof.

(Signature)

(Name)

(Date)

(Title)

EXHIBIT B

FORM OF TRANSFER

(To be signed only upon transfer of Warrant)

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto 

 the right represented by the attached Warrant to purchase 

 shares of common stock of ZEC, Inc. to which the attached Warrant relates, and appoints 

 Attorney to transfer such right on the books of 

, with full power of substitution in the premises.

Dated:  

(Signature must conform in all respects to name of 

Holder as specified on the face of the Warrant)

Address:  

Signed in the presence of:Converted by EDGARwiz

CONFIDENTIAL AGREEMENT 

Between

ZEC, INC. (“ZEC”) and

E. THOMAS LAYTON (“EXECUTIVE”)

As of:  MAY 1, 2016 (“Effective Date”)

Summary:

EXECUTIVE and ZEC (collectively, the “PARTIES”) agree to work together as per the terms and conditions in this agreement (the “AGREEMENT”) in the strategic development, business development, and financial planning of ZEC and ZEC’s affiliates in the specialty chemicals business, specifically in the environmental remediation product licensing and other businesses as defined from time to time (collectively, the “BUSINESS”). The PARTIES intend that the EXECUTIVE shall be a consultant to and an independent contractor of ZEC until such time as a formal employment contract is executed between the PARTIES or June 30, 2016, whichever comes first.  

Title:

Chairman & Chief Executive Officer

Responsibilities:

Primary focus shall be on overseeing all aspects of the BUSINESS including, but not limited to personnel, capital raising, sales, operations, product development, strategic development, business development, and financial planning.  EXECUTIVE shall report to the Board of Directors.  ZEC recognizes that EXECUTIVE has other business interests that require EXECUTIVE’S time.  However, EXECUTIVE agrees to devote the majority of his time to ZEC to achieve objectives as agreed upon by the PARTIES.

 

Existing Compensation:

EXECUTIVE has accrued compensation at the rate of Twelve Thousand Five Hundred Dollars ($12,500) per month through April 30, 2016.  As of the EFFECTIVE DATE, ZEC owed EXECUTIVE Sixty-Two Thousand Five Hundred Dollars ($62,500).

Fees:

Twelve Thousand Five Hundred Dollars ($12,500) per month beginning as of the EFFECTIVE DATE and continuing for the INITIAL TERM as defined herein payable by check or wire to EXECUTIVE or assigns in advance on the 1st day of each month (the “FEES”).  If the AGREEMENT continues for a SECOND TERM as defined herein, the FEES shall be increased by 10%. 

Term:

The initial term shall be for twelve (12) months (the “INITIAL TERM”).  The AGREEMENT shall automatically extend for an additional twelve (12) months (the “SECOND TERM”) unless cancelled by either party upon sixty (60) days notice prior to the end of the INITIAL TERM.

Allowance: 

ZEC agrees to pay EXECUTIVE an allowance for healthcare expenses of Two Thousand Dollars ($2,000) per month (the “ALLOWANCE”).

Expenses:

ZEC agrees to immediately reimburse any and all direct expenses incurred by the EXECUTIVE in the performance of duties related to ZEC and the BUSINESS.

Bonus:

ZEC agrees that the Board of Directors shall review the performance of the EXECUTIVE on a calendar year basis and provide a discretionary bonus (the “BONUS”) the basis of which includes, but is not limited to:  market value, share price, revenues, gross profits, operating profits, net profits, liquidity, and future prospects.  The BONUS shall be targeted to 100% of the EXECUTIVES annual 

FEES.  The BONUS shall be paid upon filing of the annual 10K report with the SEC.  If ZEC has insufficient liquidity to pay the BONUS, ZEC may pay such amount in its common stock.

Equity:

ZEC agrees to issue to EXECUTIVE or its assigns a ten (10) year option to purchase 500,000 shares of ZEC common stock upon acceptance of the Company’s stock option incentive plan at an exercise price per common share to be determined by the Board of Directors.

Confidentiality:

The PARTIES agree that from the date this AGREEMENT is signed until they mutually agree otherwise, they will keep the provisions of this AGREEMENT strictly confidential.  The PARITES shall not disclose or discuss this AGREEMENT or the terms and conditions contained herein with any party not bound by a non-disclosure agreement with the BUSINESS or the PARTIES; except that this AGREEMENT or portions hereof may be disclosed as required by law, within each party’s internal organization, and to third parties serving as legal, accounting, financial, investment or other advisors who need to know such information for the purpose of representing such disclosing party in connection with the BUSINESS.

Non-Compete:

The EXECUTIVE agrees that as long as ZEC is not in default hereunder, that the EXECUTIVE shall not compete with the BUSINESS for a period of one (1) year after any termination of services provided by EXECUTIVE to the BUSINESS.   

Termination:  

If for any reason ZEC no longer desires the services of the EXECUTIVE, then ZEC may terminate EXECUTIVE with sixty (60) days prior notice (“NOTICE PERIOD”), and shall owe the terminated EXECUTIVE, i) if end of NOTICE PERIOD is within the INITIAL TERM, FEES equivalent to such number of months the EXECUTIVE was under contract with ZEC, or ii) if end of NOTICE PERIOD is within the SECOND TERM, twelve (12) months of FEES.  ZEC shall also owe EXECUTIVE any other unpaid but accrued compensation, fees, equity, unreimbursed expenses as defined herein, or as otherwise agreed between the PARTIES, as of the notice delivery date plus the NOTICE PERIOD (“TERMINATION DATE”).

If for any reason the EXECUTIVE no longer desires to provide services to ZEC or ZEC terminates the services of the EXECUTIVE for “cause” (as defined below), then there shall be no requirement for a NOTICE PERIOD and no additional FEES shall be due.

“Cause” means: (i) EXECUTIVE’S failure to perform his duties hereunder, as determined in good faith by ZEC’s Board of Directors; (ii) EXECUTIVE'S failure to, within the scope of his duties hereunder, comply with any valid and legal directive of ZEC’s Board of Directors; (iii) EXECUTIVE'S engagement in dishonesty, illegal conduct or intentional misconduct which is materially injurious to the BUSINESS; (iv) EXECUTIVE'S embezzlement, misappropriation or fraud; (v) EXECUTIVE'S conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent) or a crime that constitutes a misdemeanor involving moral turpitude; (vi) EXECUTIVE'S violation of a material policy of ZEC; or (vii) EXECUTIVE'S breach of any material obligation under the AGREEMENT.  Other than for (iii), (iv) or (v) above, EXECUTIVE shall be given notice and a thirty (30) day right to cure any of the above.

Non-circumvention:

In addition, the PARTIES agree not to enter into other agreements or arrangements with the intent to circumvent the general intent of this AGREEMENT or otherwise dilute the compensation interests of the EXECUTIVE.  Further, EXECUTIVE agrees to introduce business opportunities related to the BUSINESS, with which EXECUTIVE has a business relationship, 

2

to ZEC prior to introducing them to other entities in which EXECUTIVE may or may not have an economic interest unless he is otherwise contractually obligated to do so.  

Effect and Acceptance

The proposals contained in this AGREEMENT are presented in good faith, and 

of this AGREEMENT:

shall be construed to be the agreement between the PARTIES until such time as the a more formal agreement is completed.  

The terms and conditions proposed in this AGREEMENT may need to be adjusted in light of tax, accounting or legal advice or for regulatory reasons.

This AGREEMENT shall be governed by the laws of the State of Texas, without giving effect to its conflict or choice of laws.

Any dispute or claim arising out of or related to this AGREEMENT shall be submitted to and decided by binding arbitration, administered exclusively by Dispute Prevention & Resolution, Inc., and shall be conducted consistent with the rules, regulations and requirements thereof as well as any requirements imposed by state law. Any arbitral award determination shall be final and binding upon the PARTIES.

This AGREEMENT may be executed in counterparts, each of which shall constitute an original.  Delivery of an executed counterpart of a signature page to this letter by facsimile or email shall be effective as delivery of a manually executed signature page hereto.

This AGREEMENT shall be valid and binding when approved by ZEC and by EXECUTIVE.

E. Thomas Layton

By:  _______________________________

Date:   _____________________________

ZEC, INC.

William E. Goodman, Acting Chief Financial Officer

By:  _______________________________

Date:   _____________________________

Page 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]